SCHEMBL19166161

SCHEMBL19166161

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(c4)-c4ccccc4-c4ccccc4C54c5ccccc5-c5ccccc54)cc3)c3cccc4oc5ccccc5c34)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
PLA2G10 O15496 1/20 0.31
PDK2 Q15119 1/20 0.31
MEN1 O00255 1/20 0.30
APAF1 O14727 1/20 0.30
NPC1 O15118 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30
XBP1 P17861 1/20 0.30
PTBP1 P26599 1/20 0.30
HTT P42858 1/20 0.30
RAB9A P51151 1/20 0.30
GALK1 P51570 1/20 0.30
BLM P54132 1/20 0.30
SMAD3 P84022 1/20 0.30
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19168614 1.00 PLA2G2A (0.33) PLA2G2APLA2G4APLA2G10PDK2MEN1
SCHEMBL19166071 0.96 PLA2G2A (0.30) PLA2G2APLA2G4AALOX5
SCHEMBL19167366 0.96 PLA2G2A (0.30) PLA2G2APLA2G4AALOX5
SCHEMBL17461731 0.94 PLA2G2A (0.31) PLA2G2APLA2G4AALOX5
SCHEMBL19166885 0.94 PDK2 (0.36) PLA2G2APLA2G4APLA2G10PDK2MEN1
SCHEMBL19167705 0.94 PDK2 (0.36) PLA2G2APLA2G4APLA2G10PDK2MEN1
SCHEMBL19163846 0.93 PLA2G2A (0.30) PLA2G2APLA2G4A
SCHEMBL19166138 0.91 PDK2 (0.31) PLA2G2APLA2G4APDK2ALOX5
SCHEMBL19168748 0.91 PDK2 (0.31) PLA2G2APLA2G4APDK2ALOX5
SCHEMBL19394728 0.91 AHR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10424744-B2 Compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-09-24 US disclosed
US-20170213971-A1 Novel compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2017-07-27 US disclosed
US-20170213971-A1 Novel compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2017-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10424744-B2 Compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 PLA2G2A 1570/4885PLA2G4A 2409/4885PLA2G10 1843/4885
US-20170213971-A1 Novel compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 PLA2G2A 1330/4885PLA2G4A 2323/4885PLA2G10 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.